Novo Nordisk Secures Future in Liver Disease, Acquires Akero Therapeutics in Landmark Deal
The Silent Threat Within: How Common Fatty Liver Transforms into a Deadly Disease
The Silent Epidemic: How Obesity is Fueling a Surge in Early-Onset Type 2 Diabetes
Pfizer's Bold Gambit: Unleashing New Weapons in the Global Battle Against Obesity
The Silent Epidemic: How Malnutrition Fuels a Hidden Form of Diabetes